These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21321143)

  • 21. Lipoprotein Transport: Greasing the Machines of Outer Membrane Biogenesis: Re-Examining Lipoprotein Transport Mechanisms Among Diverse Gram-Negative Bacteria While Exploring New Discoveries and Questions.
    Grabowicz M
    Bioessays; 2018 Apr; 40(4):e1700187. PubMed ID: 29512860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic uptake into gram-negative bacteria.
    Hancock RE; Bell A
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):713-20. PubMed ID: 2850910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Cefotaxime- and Ciprofloxacin-Resistant Commensal Escherichia coli Originating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates.
    Lambrecht E; Van Meervenne E; Boon N; Van de Wiele T; Wattiau P; Herman L; Heyndrickx M; Van Coillie E
    Microb Drug Resist; 2018; 24(6):707-717. PubMed ID: 29148895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Characterization of the Major Porin of Desulfovibrio vulgaris Hildenborough.
    Zeng L; Wooton E; Stahl DA; Walian PJ
    J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28874410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impermeability to quinolones in gram-positive and gram-negative bacteria.
    Bryan LE; Bedard J
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):232-9. PubMed ID: 1864283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Uptake Across Gram-Negative Outer Membranes: Better Predictions Towards Better Antibiotics.
    Ferreira RJ; Kasson PM
    ACS Infect Dis; 2019 Dec; 5(12):2096-2104. PubMed ID: 31593635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switchable Control of Antibiotic Activity: A Shape-Shifting "Tail" Strategy.
    Chang J; Chen Y; Xu Z; Wang Z; Zeng Q; Fan H
    Bioconjug Chem; 2018 Jan; 29(1):74-82. PubMed ID: 29232112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.
    Tegos G; Stermitz FR; Lomovskaya O; Lewis K
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3133-41. PubMed ID: 12234835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amelioration of the Fitness Costs of Antibiotic Resistance Due To Reduced Outer Membrane Permeability by Upregulation of Alternative Porins.
    Knopp M; Andersson DI
    Mol Biol Evol; 2015 Dec; 32(12):3252-63. PubMed ID: 26358402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer membrane permeability and antibiotic resistance.
    Delcour AH
    Biochim Biophys Acta; 2009 May; 1794(5):808-16. PubMed ID: 19100346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
    Debbia E; Mannelli S; Gianrossi G; Schito GC
    Drugs Exp Clin Res; 1987; 13(4):213-7. PubMed ID: 3304918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
    Pace J; Bertasso A; Georgopapadakou NH
    Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug discovery strategies to outer membrane targets in Gram-negative pathogens.
    Brown DG
    Bioorg Med Chem; 2016 Dec; 24(24):6320-6331. PubMed ID: 27178386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance.
    Dornbusch K
    J Antimicrob Chemother; 1990 Aug; 26(2):269-78. PubMed ID: 2211458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are outer-membrane targets the solution for MDR Gram-negative bacteria?
    Walker SS; Black TA
    Drug Discov Today; 2021 Sep; 26(9):2152-2158. PubMed ID: 33798647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.